Related Experiment Video
Updated: Dec 23, 2025

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
Complementopathies and precision medicine
Eleni Gavriilaki1, Robert A Brodsky2
1Hematology Department, G. Papanicolaou Hospital, Thessaloniki, Greece.
Insights
Precision medicine is advancing complement diagnostics and therapeutics for complement-mediated diseases. This review covers complement biology, novel insights, and its role in various diseases, guiding future research.
Area of Science:
- Immunology
- Precision Medicine
Background:
- The complement system, a key part of innate immunity, is increasingly recognized for its role in various diseases.
- Complement-mediated diseases (complementopathies) represent a growing area of clinical research and therapeutic development.
Purpose of the Study:
- To provide a state-of-the-art review of complement biology and its clinical applications.
- To explore novel insights into complement pathways relevant to patient care.
- To discuss the expanding role of complement in diverse medical disciplines and the future of precision medicine.
Main Methods:
- Literature review of current understanding of complement biology.
- Analysis of ongoing and published clinical trials involving complement inhibitors.
- Synthesis of information across hematology, nephrology, obstetrics, transplantation, rheumatology, and neurology.
Main Results:
- Identified numerous complement-mediated diseases with active clinical trials for complement inhibitors.
- Highlighted the expanding scope of complement's involvement in diseases beyond traditional immunology.
- Emphasized the potential for precision medicine approaches in managing complementopathies.
Conclusions:
- Enhanced understanding of complement diagnostics and therapeutics is crucial for clinical practice.
- This review provides a foundation for future research in precision medicine for complement-mediated diseases.
- The field of complementopathies is rapidly evolving, offering new therapeutic avenues.
Abstract:
The renaissance of complement diagnostics and therapeutics has introduced precision medicine into a widened field of complement-mediated diseases. In particular, complement-mediated diseases (or complementopathies) with ongoing or published clinical trials of complement inhibitors include paroxysmal nocturnal hemoglobinuria, cold agglutinin disease, hemolytic uremic syndrome, nephropathies, HELLP syndrome, transplant-associated thrombotic microangiopathy, antiphospholipid antibody syndrome, myasthenia gravis, and neuromyelitis optica. Recognizing that this field is rapidly expanding, we aim to provide a state-of-the-art review of (a) current understanding of complement biology for the clinician, (b) novel insights into complement with potential applicability to clinical practice, (c) complement in disease across various disciplines (hematology, nephrology, obstetrics, transplantation, rheumatology, and neurology), and (d) the potential future of precision medicine. Better understanding of complement diagnostics and therapeutics will not only facilitate physicians treating patients in clinical practice but also provide the basis for future research toward precision medicine in this field.
More Related Videos
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Genomics
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Proteomics
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Complement System

